跳至主要内容
临床试验/NCT07804095
NCT07804095Enrolling By Invitation不适用

AI-Supported Care Engagement for Next-step Delivery - Medicare Advantage (ASCEND-MA)

Intermountain Health Care, Inc.1 个研究点 分布在 1 个国家目标入组 9,906 人开始时间: 2026年8月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
9,906
试验地点
1
主要终点
Cumulative payer-paid health care spending per participant

研究概览

简要总结

ASCEND-MA is an embedded, health-services study of at-risk Medicare Advantage members attributed to Intermountain Health in Utah. Participants are quasi-randomized based on their medical-record-number parity to either AI-supported, nurse-reviewed proactive care navigation or usual care. The study will evaluate whether the program changes cumulative payor-paid healthcare spending over 12 months.

详细描述

An additional ancillary, separately consented consumer-experience sub-study will sample roughly 45 intervention-arm participants for surveys and interviews about the acceptability, burden, and perceived usefulness of the care-navigation workflow.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • .Enrolled in an eligible Medicare Advantage plan and attributed to Intermountain Health in Utah.
  • Continuous Medicare Advantage enrollment for at least 6 months before the index date.
  • PRM Rising-Risk score (an internally derived prediction model) of at least 0.70 and Current-Risk score below 0.95 at index
  • Predicted year-over-year cost increase of at least 30%.
  • At least one targeted chronic condition: diabetes mellitus, heart failure, chronic obstructive pulmonary disease, chronic kidney disease, hypertension, or hyperlipidemia.

排除标准

  • Hospice enrollment at index.
  • End-stage renal disease requiring chronic dialysis at index.
  • Active oncology treatment at index.
  • Long-term institutional residence, including skilled-nursing-facility residence, at index.
  • Primary language cannot be supported through patient-directed outreach and no feasible alternative care-team communication pathway is available.

研究组 & 干预措施

AI Supported Rising Risk Care Navigation

Experimental

Participants receive routine clinical care plus the AI Supported Rising Risk Care Navigation strategy. The strategy periodically assesses for care opportunities; every candidate nudge undergoes human clinical review before routing or outreach, and no outreach occurs when no clinically appropriate action is identified

干预措施: AI-Supported Rising-Risk Care Navigation (Other)

Usual Care

No Intervention

Participants receive routine clinical care and existing care-management services under standard eligibility and operating rules. The study introduces no AI-supported care-navigation nudges for this arm and withholds no otherwise available care because of assignment

结局指标

主要结局

Cumulative payer-paid health care spending per participant

时间窗: 1 year

Mean cumulative payer-paid health care spending (in U.S. dollars) recorded in claims per participant.

次要结局

  • Rate of All-Cause Acute-Care Episodes(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验